Pyramax 180mg/60mg - Advanced Malaria Treatment in Nigeria

Pyramax is a potent, fixed-dose combination antimalarial medicine used to treat uncomplicated malaria caused by Plasmodium falciparum and Plasmodium vivax. This treatment combines two powerful active ingredients, Pyronaridine tetraphosphate (180mg) and Artesunate (60mg), which work together to rapidly clear malaria parasites from the blood.

Why Choose Pyramax?

In Nigeria, where malaria remains a significant health concern, having a fast-acting and reliable treatment is essential. Pyramax belongs to the Artemisinin-based Combination Therapy (ACT) class, the gold standard for malaria treatment. It is formulated to provide sharp relief from malaria symptoms and ensure a high cure rate.

Dosage and Administration

Pyramax is typically administered as a once-daily dose for three consecutive days. The number of tablets depends on the patient's body weight (usually for adults and children over 20kg). It is recommended to take the tablets with food to aid absorption.

This specific pack contains 90 film-coated tablets, which is a clinical or wholesale packaging configuration. It is ideal for healthcare providers or for distribution in a clinical setting.

Safety and Precautions

While Pyramax is highly effective, it should not be used by patients with severe liver disease. Always consult a healthcare professional before starting treatment. Common side effects may include nausea, headache, or dizziness. If you have questions about the suitability of this medication, you can contact a GoMed pharmacist for professional advice.

Store in a cool, dry place. Always complete the full treatment course even if symptoms disappear.